Stable gene transfer to muscle using non-integrating lentiviral vectors
- PMID: 17700544
- DOI: 10.1038/sj.mt.6300281
Stable gene transfer to muscle using non-integrating lentiviral vectors
Abstract
Human immunodeficiency virus (HIV)-based lentiviral vectors (LVs) hold immense promise for gene delivery applications because of their relatively large packaging capacity and their ability to infect a range of cell types. The genome of HIV non-specifically integrates into the host genome, and this promotes efficient, stable transgene expression in dividing cells. However, integration can also be problematic because of variations in gene expression among cells, possible gene silencing and, most importantly, insertional mutagenesis which can lead to undesirable effects such as malignant transformation. In order to alleviate these problems, we have developed a range of non-integrating LVs (NILVs) by introducing point mutations into the catalytic site, chromosome binding site, and viral DNA binding site of the viral integrase (IN). In addition, we have mutated the IN attachment (att) sites within the HIV long terminal repeats (LTRs). All of the vectors produced show efficient reverse transcription and transgene expression in dividing cells and prolonged expression in non-dividing myotubes. Finally, we show that NILV can be used for achieving highly effective gene transfer and expression in muscle in vivo.
Similar articles
-
Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.Methods Mol Biol. 2016;1448:159-73. doi: 10.1007/978-1-4939-3753-0_12. Methods Mol Biol. 2016. PMID: 27317180
-
The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.Viruses. 2020 Sep 29;12(10):1103. doi: 10.3390/v12101103. Viruses. 2020. PMID: 33003492 Free PMC article. Review.
-
Integrase-defective lentiviral vectors: progress and applications.Gene Ther. 2010 Feb;17(2):150-7. doi: 10.1038/gt.2009.135. Epub 2009 Oct 22. Gene Ther. 2010. PMID: 19847206 Review.
-
Non-integrating lentiviral vectors.Curr Gene Ther. 2008 Dec;8(6):430-7. doi: 10.2174/156652308786848012. Curr Gene Ther. 2008. PMID: 19075626 Review.
-
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9. doi: 10.1073/pnas.0606197103. Epub 2006 Nov 9. Proc Natl Acad Sci U S A. 2006. PMID: 17095605 Free PMC article.
Cited by
-
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.Biomedicines. 2023 Apr 30;11(5):1334. doi: 10.3390/biomedicines11051334. Biomedicines. 2023. PMID: 37239005 Free PMC article. Review.
-
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases.J Clin Med. 2023 Jan 29;12(3):1046. doi: 10.3390/jcm12031046. J Clin Med. 2023. PMID: 36769694 Free PMC article. Review.
-
Complex Relationships between HIV-1 Integrase and Its Cellular Partners.Int J Mol Sci. 2022 Oct 15;23(20):12341. doi: 10.3390/ijms232012341. Int J Mol Sci. 2022. PMID: 36293197 Free PMC article. Review.
-
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells.Cell Rep. 2022 Apr 12;39(2):110650. doi: 10.1016/j.celrep.2022.110650. Cell Rep. 2022. PMID: 35417711 Free PMC article.
-
Advancement and Applications of Platelet-inspired Nanoparticles: A Paradigm for Cancer Targeting.Curr Pharm Biotechnol. 2023;24(2):213-237. doi: 10.2174/1389201023666220329111920. Curr Pharm Biotechnol. 2023. PMID: 35352648 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous